Marshall Wace LLP Buys 65,994 Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS)

Marshall Wace LLP lifted its position in Sensus Healthcare, Inc. (NASDAQ:SRTS) by 99.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 132,286 shares of the company’s stock after purchasing an additional 65,994 shares during the period. Marshall Wace LLP owned about 0.81% of Sensus Healthcare worth $915,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Arrowstreet Capital Limited Partnership grew its stake in shares of Sensus Healthcare by 81.2% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 150,150 shares of the company’s stock worth $1,039,000 after buying an additional 67,269 shares in the last quarter. O Shaughnessy Asset Management LLC raised its holdings in shares of Sensus Healthcare by 65.1% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 93,248 shares of the company’s stock valued at $645,000 after purchasing an additional 36,785 shares in the last quarter. Integrated Quantitative Investments LLC purchased a new stake in Sensus Healthcare during the fourth quarter worth $251,000. Sigma Planning Corp bought a new stake in Sensus Healthcare during the 4th quarter valued at $215,000. Finally, Virtu Financial LLC purchased a new position in Sensus Healthcare in the fourth quarter valued at about $189,000. Institutional investors own 25.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Lake Street Capital decreased their price objective on Sensus Healthcare from $18.00 to $13.00 and set a “buy” rating for the company in a report on Tuesday, March 11th. HC Wainwright reiterated a “buy” rating and issued a $12.00 target price on shares of Sensus Healthcare in a research report on Friday, April 4th.

Sensus Healthcare Trading Down 3.4 %

Sensus Healthcare stock opened at $4.30 on Thursday. The stock’s 50 day simple moving average is $4.67 and its two-hundred day simple moving average is $6.30. Sensus Healthcare, Inc. has a 12 month low of $3.48 and a 12 month high of $9.33. The firm has a market cap of $70.93 million, a PE ratio of 10.75 and a beta of 1.11.

Sensus Healthcare (NASDAQ:SRTS) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.09 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.01). Sensus Healthcare had a return on equity of 12.60% and a net margin of 15.90%. On average, equities research analysts forecast that Sensus Healthcare, Inc. will post 0.32 EPS for the current year.

About Sensus Healthcare

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.